Health
Even low-dose oral glucocorticoid use associated with increased CV risk – medwireNews
UK research has identified a “strong dose-dependent” association between oral glucocorticoid use and CVD risk among people with immune-mediated diseases, with an…
medwireNews: UK research has identified a strong dose-dependent association between oral glucocorticoid use and cardiovascular disease (CVD) risk among people with immune-mediated diseases, with an increased risk seen even at prednisolone-equivalent doses of less than 5 mg/day.
These results highlight the importance of prompt and regular monitoring of cardiovascular risk and use of primary prevention treatment at all glucocorticoid doses, write the researchers in PLOS Medicine.
Mar Pujades-Rodriguez…
-
General15 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business15 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General17 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General18 hours agoAlbanese beats drum on economy as trade clouds gather